Lv6
3132 积分 2024-07-22 加入
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
1个月前
已完结
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
1个月前
已完结
Errors in Figure 1
1个月前
已关闭
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
1个月前
已完结
Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E-Mutant Colorectal Cancer
1个月前
已完结
Impact of HER2 on prognosis and benefit from adjuvant chemotherapy in stage II/III gastric cancer patients: a multicenter observational study
1个月前
已完结
ADC for SCLC Clears Phase I
5个月前
已关闭
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
6个月前
已完结
FUNCTIONAL ANALYSIS AND TREATMENT OF MULTIPLY CONTROLLED INAPPROPRIATE MEALTIME BEHAVIOR
6个月前
已完结
[Expert consensus on the early diagnosis and treatment of colorectal cancer in China (2023 edition)]
6个月前
已完结
皖公网安备34019202002308
